Angelina Jolie

Image by getty images
What was Jewish about Angelina Jolie’s decision to have her breasts surgically removed? Everything.
The Hollywood superstar stunned million of fans with the stark and eloquent announcement that she had chosen to proactively undergo the procedure to reduce her risk of contracting breast cancer. Jolie, whose mother died from breast cancer, explained that she took the dramatic step after discovering she carries the BRCA gene mutation, which is disproportionately prevalent in Ashkenazi Jews.
It’s a wrenching choice for any woman, as thousands of Jewish families have discovered firsthand. It may be even tougher for the willowy Jolie, 38, whose acting ability and jaw-dropping beauty have earned her an enviable livelihood.
Jolie, who has made headlines for her A-list partnership to Brad Pitt and their growing brood of mostly adopted children, could have kept quiet about what is surely the most personal of choices. Instead, she enriched the debate about breast cancer and the conversation surrounding the burden that many Jewish women bear because of the BRCA mutation.
Within days, doctors reported dramatic increases in numbers of women seeking testing for the dreaded mutation. Others asked what they could do to inform friends or synagogue members about their potential ticking time bombs. The news inspired Jewish activists to pursue what turned out to be a winning Supreme Court battle against a biotech company’s effort to patent the mutated gene.
Call it a Jewish teachable moment, courtesy of one of the most beautiful women on the planet.
Hello, fellow Forward reader! I’m Joel Brown, a Forward reader and supporter for more than 15 years, and currently the chair of the board of directors.
I’m an avid Forward reader because it ticks so many of my essential boxes: excellent journalism, Jewish focus and diverse viewpoints. In today’s political climate, what I most appreciate is the Forward’s independence — made possible by the generosity of its membership.
The Forward is committed to bringing you unbiased, nuanced Jewish news. From my position as board chair, I see an exciting future as we expand our position as the definitive independent voice of contemporary American Judaism.
That’s why I’m paying it Forward, by matching $36,000 of reader gifts. It’s an investment in the Forward’s newsroom, to continue telling the American Jewish story with truth and independence.
— Joel Brown, Forward board chair
